Atobe J H, Hirata M H, Hoshino-Shimizu S, Schmal M R, Mamizuka E M
Pharmaceutical Science Faculty, Department of Clinical and Toxicological Analysis, University of São Paulo, Brazil.
J Clin Lab Anal. 2000;14(4):193-9. doi: 10.1002/1098-2825(2000)14:4<193::aid-jcla9>3.0.co;2-2.
A one-step polymerase chain reaction (Heminested-PCR) was designed to target the 16S rRNA fragment simultaneously using a set of primers for the universal bacterial group and a Neisseria meningitidis species-specific sequence for diagnostic purposes. The diagnostic features of the Heminested-PCR were evaluated in the study of 168 cerebrospinal fluid (CSF) specimens from 84 patients with a N. meningitidis infection, meningitis caused by unrelated bacteria and other etiologies (57 patients), or suspicious cases (27 patients) with clinical symptoms of bacterial meningitis but with negative results from bacteriological procedures. About 90% of patients with bacterial meningitis, including those suspicious cases, had prior antibiotic therapy. The sensitivity, specificity, positive, and negative predictive values found in relation to culture and/or microscopy were 91.7, 100, 100, 100, and 90.5%, respectively. In patients suspected of having bacterial meningitis, the Heminested-PCR revealed 51.9% (14 patients) positive for N. meningitidis infection and 40.7% (11 patients) positive for unrelated bacterial infections. The agreement of the Heminested-PCR with culture and/or microscopy was high and ranked as almost perfect (kappa indices > 0.856), in contrast to its agreement with other techniques. These findings speak in favor of the molecular diagnosis of meningococcal meningitis in patients who are culture- and/or microscopy-negative, due to their prior antibiotic treatment.
设计了一种一步法聚合酶链反应(半巢式聚合酶链反应),使用一组针对通用细菌群的引物和一个脑膜炎奈瑟菌物种特异性序列同时靶向16S rRNA片段,用于诊断目的。在对84例患有脑膜炎奈瑟菌感染、由无关细菌引起的脑膜炎和其他病因(57例患者)或有细菌性脑膜炎临床症状但细菌学检查结果为阴性的可疑病例(27例患者)的168份脑脊液(CSF)标本的研究中,评估了半巢式聚合酶链反应的诊断特征。约90%的细菌性脑膜炎患者,包括那些可疑病例,之前接受过抗生素治疗。与培养和/或显微镜检查相比,其敏感性、特异性、阳性预测值和阴性预测值分别为91.7%、100%、100%、100%和90.5%。在疑似患有细菌性脑膜炎的患者中,半巢式聚合酶链反应显示51.9%(14例患者)脑膜炎奈瑟菌感染呈阳性,40.7%(11例患者)无关细菌感染呈阳性。半巢式聚合酶链反应与培养和/或显微镜检查的一致性很高,几乎达到完美(kappa指数>0.856),与其与其他技术的一致性形成对比。这些发现支持对因先前接受抗生素治疗而培养和/或显微镜检查呈阴性的患者进行脑膜炎球菌性脑膜炎的分子诊断。